Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Hive Digital Technologies Ltd.

Start price
Target price
Perf. (%)
€4.10
19.09.22
-
19.09.23
-38.54%
08.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
-18.43%
08.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
Alumil S.A.

Start price
Target price
Perf. (%)
€1.93
17.09.22
€0.000
17.09.23
-8.90%
01.10.22

Revenue decline/stagnation expected
Risky balance sheet
Increased challenges to pay loans and raise capital
Below average Management
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€7.79
17.09.22
€3.00
17.09.23
-22.91%
01.10.22

High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
buy
Sabina Gold & Silver Corp.

Start price
Target price
Perf. (%)
€0.76
17.09.22
€1.00
17.09.23
-2.01%
20.09.22

Top 10 in its market
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Known brand
buy
Proton Motor Power Systems plc

Start price
Target price
Perf. (%)
€0.13
15.09.22
-
15.09.23
-22.46%
16.09.23

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
buy
Proton Motor Power Systems plc

Start price
Target price
Perf. (%)
€0.13
14.09.22
-
14.09.23
19.88%
30.11.22

Toughbuilt Industries Inc.

Start price
Target price
Perf. (%)
€2.77
13.09.22
€1.00
13.09.23
-19.91%
17.09.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.96
13.09.22
-
13.09.23
-17.60%
18.09.22

Could be worthwhile Investment >10% per year
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€29.73
13.09.22
-
13.09.23
20.64%
13.09.23

NeXR Technologies SE

Start price
Target price
Perf. (%)
€1.00
08.09.22
€0.000
08.09.23
-96.59%
09.09.23

Business model of the past or high risk
Little known brand
Significant cyclical dependencies
Below average Marketposition
Ahlers AG ST

Start price
Target price
Perf. (%)
€1.09
08.09.22
€0.000
08.09.23
-18.35%
17.09.22

Probably not worthwhile Investment
Bad culture
Below average Management
buy
Altimmune

Start price
Target price
Perf. (%)
€20.50
07.09.22
€38.00
30.04.25
-77.51%
05.05.23

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
15.44%
19.07.24

Could be very worthwhile Investment >20% year
Bitcoin Group SE

Start price
Target price
Perf. (%)
€20.66
07.09.22
€19.00
07.09.23
-2.23%
03.10.22

Very low/no dividend yield expected
Bad rating
Risky balance sheet
ROE lower than 5% per year
buy
Vizsla Silver Corp.

Start price
Target price
Perf. (%)
€1.28
06.09.22
€2.00
06.09.23
-25.39%
07.09.23

Could be very worthwhile Investment >20% year
buy
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€4.55
06.09.22
-
06.09.23
-53.45%
06.09.23

buy
ETFS Commodity Securities Ltd

Start price
Target price
Perf. (%)
-
06.09.22
-
06.09.23
0.00%
06.09.23

buy
ETFS Commodity Securities Ltd

Start price
Target price
Perf. (%)
-
06.09.22
-
06.09.23
0.00%
06.09.23

buy
ETFS Commodity Securities Ltd

Start price
Target price
Perf. (%)
-
06.09.22
-
06.09.23
0.00%
06.09.23

buy
ETFS Industrial Metals

Start price
Target price
Perf. (%)
-
06.09.22
-
06.09.23
0.00%
06.09.23

buy
Rock Tech Lithium Inc.

Start price
Target price
Perf. (%)
€2.62
05.09.22
€4.00
05.09.23
-6.88%
17.09.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group